| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.0007 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |